| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/11/2011 | CA2378883C Methods of reducing microbial resistance to drugs |
| 01/11/2011 | CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/11/2011 | CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/11/2011 | CA2205092C Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 01/11/2011 | CA2156360C Adhesion receptor antagonists |
| 01/06/2011 | WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein |
| 01/06/2011 | WO2011002067A1 Heterocyclic compound and use thereof |
| 01/06/2011 | WO2011002066A1 Peptide and use thereof |
| 01/06/2011 | WO2011002026A1 Amyloid fibril formation inhibitor and use thereof |
| 01/06/2011 | WO2011002011A1 Combined medicine of sglt1 inhibitor and dpp-iv inhibitor |
| 01/06/2011 | WO2011002001A1 Combined medicine of pyrazole derivative and biguanide drug |
| 01/06/2011 | WO2011001931A1 Novel oxadiazole derivative |
| 01/06/2011 | WO2011001913A1 Ppar ligand |
| 01/06/2011 | WO2011001897A1 Medicinal agent and method for treatment of intractable chronic hepatitis c |
| 01/06/2011 | WO2011000958A1 Compounds targeting the cation-independent mannose 6-phosphate receptor |
| 01/06/2011 | WO2010056985A8 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003850 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 01/06/2011 | US20110003831 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 01/06/2011 | US20110003748 Method of treatment and compositions of D-chiro inositol and phosphates thereof |
| 01/06/2011 | US20110003746 Protein variants |
| 01/06/2011 | US20110002982 Lipid carrier compositions with enhanced blood stability |
| 01/06/2011 | US20110002912 Composition |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002908 Treatment of a-galactosidase a deficiency |
| 01/06/2011 | US20110002875 Method for treating amyloidosis |
| 01/06/2011 | US20110002859 Chewing gum containing eucalyptus extract |
| 01/06/2011 | US20110002843 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 01/06/2011 | CA2766614A1 Compounds targeting the cation-independent mannose 6-phosphate receptor |
| 01/05/2011 | EP2270505A1 A method of screening a cell death inhibitor using macrophage migration inhibitory factor (MIF) |
| 01/05/2011 | EP2270191A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 01/05/2011 | EP2270107A1 Compounds for Dual Photodiagnosis and Therapy |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270044A1 Liquid immunoglobulin G (lgG) product |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2269993A1 2-aminoquinazoline derivative |
| 01/05/2011 | EP2269990A1 Heterocyclic compound |
| 01/05/2011 | EP2269989A1 Iminopyridine derivative and use thereof |
| 01/05/2011 | EP2269659A1 Integrin targeted imaging agents |
| 01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269653A1 Composition for stabilizing -blocker, and transdermally absorbable preparation comprising the composition |
| 01/05/2011 | EP2269648A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 01/05/2011 | EP2269647A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 01/05/2011 | EP2269646A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 01/05/2011 | EP2269645A2 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| 01/05/2011 | EP2269621A1 Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
| 01/05/2011 | EP2269620A1 Therapeutic uses of dunaliella powder |
| 01/05/2011 | EP2269616A2 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 01/05/2011 | EP2269612A1 Eye-drop preparation and use thereof |
| 01/05/2011 | EP2269609A2 Treatment of neurodegenerative diseases and cancer of the brain with SAHA |
| 01/05/2011 | EP2269593A1 Transdermally absorbable preparation |
| 01/05/2011 | EP2269591A2 Improved pharmaceutical formulations |
| 01/05/2011 | EP2269467A1 Pasteurisation process for microbial cells and microbial oil |
| 01/05/2011 | EP2268600A1 Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions |
| 01/05/2011 | EP1623718B1 Skin collagen production promoter |
| 01/05/2011 | EP1558256B1 Pyrroloquinoline quinone and a beta blocker for the treatment of ischemia or reperfusion injury |
| 01/05/2011 | EP1463806B1 Novel cyclooxygenase variants and methods of use |
| 01/05/2011 | EP1433480B1 Medicine containing pyrimidine derivative |
| 01/05/2011 | EP1147214B1 A novel method for designing protein kinase inhibitors |
| 01/05/2011 | EP0815129B1 Ingap protein involved in pancreatic islet neogenesis |
| 01/05/2011 | DE102007052114B4 Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle A method of modulating the function of the growth or differentiation of a cell |
| 01/05/2011 | CN1905866B Tulobuterol adhesive patch |
| 01/05/2011 | CN101939337A Anti-TRKA antibodies and derivatives thereof |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101939297A Benzylpiperizine compound |
| 01/05/2011 | CN101935318A 2,3-dihydro-4(1H)- quinazolone derivative and application thereof |
| 01/05/2011 | CN101935310A Refining process of famotidine raw material |
| 01/05/2011 | CN101935303A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors |
| 01/05/2011 | CN101935301A Modulators of ATP-binding cassette transporters |
| 01/05/2011 | CN101934041A Chinese medicinal herb for treating pleurisy |
| 01/05/2011 | CN101934015A Traditional Chinese medicinal composition for treating thyroid and method for preparing dispelling-goitre cataplasm thereof |
| 01/05/2011 | CN101933972A Nitric oxide reinforcing agent and application thereof |
| 01/05/2011 | CN101933934A Novel application of ginsenoside Rb1 |
| 01/05/2011 | CN101507761B Traditional Chinese medicine composite for treating horse chronic hydrocephalus |
| 01/05/2011 | CN101297939B Chinese medicine preparation for raising weight of broiler chickens and preparation thereof |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7863306 Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | US7862813 Multivalent immunoglobulin polypeptide for treatment of immune system abnormalities |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2545813C The derivatives of pyridone and use thereof |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2491027C Novel flavone c-glycoside derivatives and compositions containing the derivatives |
| 01/04/2011 | CA2488363C O-substituted hydroxyaryl derivatives |
| 01/04/2011 | CA2481754C Antibiotic/benzoyl peroxide dispenser |
| 01/04/2011 | CA2479362C N-sulfonylurea apoptosis promoters |
| 01/04/2011 | CA2468517C Thioether substituted imidazoquinolines |
| 01/04/2011 | CA2468039C Novel peptide having angiotensin converting enzyme inhibitory effect |
| 01/04/2011 | CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/04/2011 | CA2460920C Stent coated with a sustained-release drug delivery and method for use thereof |
| 01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2451241C Unsymmetrical cyclic diamine compound |
| 01/04/2011 | CA2451238C Cyclic diamine compound with 5 membered ring groups |
| 01/04/2011 | CA2447818C Method for purifying an enzyme and purified enzyme produced according to this method, as well as use of the enzyme |